APA Цитирование

Wu, P., Cheng, C., Luo, Y., Zhang, J., Yang, S., Cheng, S., & Hung, C. (2014). Safety of rilpivirine plus nucleoside reverse-transcriptase inhibitors in HIV-infected Taiwanese with a higher prevalence of hepatitis virus infection. J Int AIDS Soc.

Chicago-стиль цитирования

Wu, Pei-Ying, Chien-Yu Cheng, Yu-Zhen Luo, Jun-Yu Zhang, Shan-Ping Yang, Shu-Hsing Cheng, and Chien-Ching Hung. "Safety of Rilpivirine Plus Nucleoside Reverse-transcriptase Inhibitors in HIV-infected Taiwanese With a Higher Prevalence of Hepatitis Virus Infection." J Int AIDS Soc 2014.

MLA-цитирование

Wu, Pei-Ying, et al. "Safety of Rilpivirine Plus Nucleoside Reverse-transcriptase Inhibitors in HIV-infected Taiwanese With a Higher Prevalence of Hepatitis Virus Infection." J Int AIDS Soc 2014.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.